Anton Uvarov

Dr. Uvarov has significant experience as an equity analyst both domestically and internationally. Prior to moving to Australia he was with Citigroup Global Markets where he spent two years as a member of New York based Healthcare team. Dr. Uvarov's technical expertise and company knowledge spreads across variety of industries and spectrum of market capitalizations with his particular interest in early stage startups. Dr. Uvarov holds a PhD degree from the University of Manitoba, Canada and an MBA degree from the University of Calgary, Canada. He is currently a Director of Actinogen Medical (ASX.ACW) - an Australian clinical stage biotechnology company developing therapies for Alzheimer's and other neurodegenerative diseases, and Imugene Limited (ASX.IMU) - an Australian immuno-oncology company.